This site is intended for healthcare professionals
Drug news

First patient enrolled in the pivotal phase III NEPTUNE trial of OV 101 for treatment of Angelman syndrome.- Ovid Therapeutics.

Read time: 1 mins
Last updated:19th Sep 2019
Published:19th Sep 2019
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest